Comité del programa
-
Tomoaki Sakamoto, PHD Section Chief, Division of Drugs
National Institute of Health Sciences, Japan -
Koki Akazawa Inspector, Office of Manufacturing Quality for Drugs
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Osamu Hiruta, PHD Manager, Quality assurance Dept., Reliability & Quality Assurance Division
Meiji Seika Pharma Co., Ltd., Japan -
Fusashi Ishikawa, PHD, MSC Associate Biopharmaceutics Research Fellow, Formulation R&D Laboratories
Sumitomo Dainippon Pharma Co., Ltd., Japan -
Motonori Kidokoro, PHD Director, Regulatory Affairs CMC
Daiichi Sankyo Pharma Development, United States -
Yoshihiro Matsuda, PHD Senior Scientist (for Quality), Pharmacist
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Kazuji Omori Inspector, Office of Manufacturing Quality for Drugs
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Mitsuo Sugiyama, PHD Deputy Director (CDMO), Business Strategy management Division
CMIC Co., Ltd., Japan -
Yutaka Takahashi Senior Manager, Pharmaceutical Planning & Control
Astellas Pharma Inc., Japan -
Yukio Hiyama, PHD Visiting Researcher
National Institute of Health Sciences, Japan
¿Tiene una cuenta?